CD8A and myeloid sarcoma: In this article, we discuss below the prevailing concept that T helper 1 (TH1), TH17, and CD8+ T cells are the major drivers of MS, whereas regulatory T cells (Tregs), perhaps plus TH2, confer protective properties.